ANLVSLABT• 6 Months (Normalized)
ANL vs LABT (Adlai Nortye Group Ltd. vs Lakewood-Amedex Biotherapeutics Inc.)
Showing Closing Date Range from Mar 29 to Sep 25, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
ANL Performance $15.83
+139.49%
Adlai Nortye Group Ltd.
Normalized Baseline0.00%
LABT Performance $1.78
+%
Lakewood-Amedex Biotherapeutics Inc.
Normalized Baseline0.00%
Alpha Spread Margin ANL LEADS
+139.49 pts
ANL outperforming by 139.49 percentage points
ANLLABT
Spread Trajectory6 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
ANL LABT
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(124 dates)
| Date | ANL Price | ANL Gain (%) | LABT Price | LABT Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 24, 2026 | $15.83 | +139.49% | $- | - | |
| Sep 23, 2026 | $15.75 | +138.28% | $1.78 | -97.94% | +236.22% |
| Sep 22, 2026 | $16.60 | +151.13% | $1.99 | -97.70% | +248.83% |
| Sep 21, 2026 | $15.57 | +135.55% | $2.05 | -97.63% | +233.18% |
| Sep 18, 2026 | $15.74 | +138.12% | $1.99 | -97.70% | +235.82% |
| Sep 17, 2026 | $15.28 | +131.16% | $1.86 | -97.85% | +229.01% |
| Sep 16, 2026 | $15.52 | +134.80% | $2.09 | -97.58% | +232.38% |
| Sep 15, 2026 | $15.00 | +126.93% | $2.17 | -97.49% | +224.42% |
| Sep 14, 2026 | $15.93 | +141.00% | $2.12 | -97.55% | +238.55% |
| Sep 11, 2026 | $15.21 | +130.11% | $2.22 | -97.43% | +227.54% |
| Sep 10, 2026 | $15.09 | +128.29% | $2.05 | -97.63% | +225.92% |
| Sep 09, 2026 | $14.70 | +122.31% | $2.32 | -97.32% | +219.63% |
| Sep 08, 2026 | $15.51 | +134.64% | $2.18 | -97.48% | +232.12% |
| Sep 04, 2026 | $15.01 | +127.08% | $1.88 | -97.83% | +224.91% |
| Sep 03, 2026 | $14.75 | +123.15% | $1.90 | -97.80% | +220.95% |
Page 1 of 9